Comments
Loading...

Kymera Therapeutics

KYMRNASDAQ
Logo brought to you by Benzinga Data
$46.44
-0.86-1.82%
At Close: -
$48.44
24.31%
After Hours: 5:49 PM EDT
15 minutes delayed

Kymera Therapeutics (NASDAQ:KYMR) Stock, Earnings Estimates, EPS, And Revenue

Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 31
EPS Estimate
$-0.840
Quarterly Revenue Estimate
$10.6M
Annual Revenue
(as of Jun 30)
$88.5M

Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Kymera Therapeutics (KYMR) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-07$-0.58$-0.6814.7 %
Mar 20242024-05-02$-0.69$-0.735.48 %
Dec 20232024-02-22$-0.25$-0.4037.5 %
Sep 20232023-11-02$-0.90$-0.72-25.0 %

Kymera Therapeutics (KYMR) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-07$25.65M$12.55M104.4 %
Mar 20242024-05-02$10.29M$13.69M-24.9 %
Dec 20232024-02-22$47.88M$41.96M14.1 %
Sep 20232023-11-02$4.73M$15.97M-70.4 %

FAQ

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics (KYMR) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?

A

The Actual EPS was $-0.58, which beat the estimate of $-0.68.

Q

What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?

A

The Actual Revenue was $25.6M, which beat the estimate of $12.6M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch